Fossaoprin SPG2

Product NDC: 70529-016
11-digit product format: 705290016
Labeler code: 70529
Product ID: 70529-016_9b1587e0-7ddd-4c19-a5b2-77a3981f55ad
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Lidocaine hydrochloride, Bupivacaine hydrochloride
Dosage form: KIT
Labeler: IT3 Medical LLC
Application: ANDA088327
Marketing category: ANDA
Marketing start: 2017-03-01
Marketing end: 0000-00-00
Active strength: 0
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	70529-016		I	Inactivated by FDA		2026-08-03
excluded package	package	70529-016	70529-016-01	I	Inactivated by FDA		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 30 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	70529-016-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	70529-016-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	70529-016-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	70529-016-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	70529-016-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	70529-016-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	70529-016-01	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	70529-016-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	70529-016-01	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	70529-016-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	70529-016-01	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	70529-016-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	70529-016-01	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	70529-016-01	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	70529-016-01	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	LIDOCAINE HYDROCHLORIDE	2%	INJECTABLE / INJECTION	AP		1984-07-31

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A088327-001	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A088327-001	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	2%	INJECTABLE / INJECTION	AP	1984-07-31	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A088327-001	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A088327-001	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A088327-001	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A088327-001	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A088327-001	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A088327-001	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A088327-001	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A088327-001	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A088327-001	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A088327-001	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A088327-001	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A088327-001	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A088327-001	AP	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A088327-001	AP	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A088327-001	AP	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A088327-001	AP	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A088327-001	AP	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A088327-001	AP	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A088327-001	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A088327-001	AP	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A088327-001	AP	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A088327-001	AP	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A088327-001	AP	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A088327-001	AP	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A088327-001	AP	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A088327-001	AP	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A088327-001	AP	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A088327-001	AP	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A088327-001	AP	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A088327-001	AP	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A088327-001	AP	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A088327-001	AP	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A088327-001	AP	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A088327-001	AP	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A088327-001	AP	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A088327-001	AP	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A088327-001	AP	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A088327-001	AP	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A088327-001	AP	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A088327-001	AP	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
070fbed5-7088-434a-a7ce-f2a64d8d40ac	Product name	2	20260107
bee66ce1-adb7-9d3b-67d9-582e4c54e80f	Product name	5	20250819
cbf85893-59ef-423f-87d4-a573c000a8b9	Product name	8	20250731
5dad6767-dcd1-b0da-8727-7f3f7bc3a435	Product name	2	20250303
860a93dc-4863-49cc-b284-6bbe8191bc48	Product name	4	20250214
eaba870a-6a9d-442e-8643-87b3f558a451	Product name	1	20250117
9b4cf230-fd05-41d5-98c6-5db9ecb27b86	Product name	1	20230117
e3a99641-4540-4894-9108-00cab3c57b7e	Product name	1	20211207
5da98533-f072-406b-9e1b-6ac19eca9926	Product name	1	20210622
7d755fa1-1087-4dcd-98f0-6d4bba479a57	Product name	3	20210602
306b993e-3140-4823-ad5e-88b708f9d2ac	Product name	1	20210510
a831e694-3663-4a83-82be-6c309429f750	Product name	2	20200608
aed701d5-9c75-dfaf-7154-cde46179faea	Product name	9	20200313
fa8b5901-e681-426f-82fe-54f6d81ec698	Product name	4	20180619
332d03e4-aa24-4b11-841a-02bf41081920	Product name	1	20171221
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070	Product name	1	20171221
68ed98f8-24c2-44a0-944a-6d36e82ce25a	Product name	1	20141222
1cd42bc2-a430-c72b-636d-991b235fbf80	Product name	1	20140508
49fa150c-f0de-cce7-3d9c-993ed81c5698	Product name	1	20140508
4d7ae718-ed00-bae8-2abe-9eaec1eef7ff	Product name	1	20140508
9137811f-f279-8640-5aeb-99fa2145d64d	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
70529-016-01	2023-07-28	C162847	48780-1	d6a99b39-d337-a426-e053-dadaa90af4c2	Fossaoprin SPG2 Injection System
70529-016-01	2022-03-01	C162847	48780-1	d6a99b39-d337-a426-e053-dadaa90af4c2	Fossaoprin SPG2 Injection System
70529-016-01	2022-01-28	C162847	48780-1	d6a99b39-d337-a426-e053-dadaa90af4c2	Fossaoprin SPG2 Injection System

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
70529-016-01	Fossaoprin SPG2	1 in 1 PACKAGE	KIT	1		3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
70529-016	FOSSAOPRIN SPG2 (LIDOCAINE HYDROCHLORIDE, BUPIVACAINE HYDROCHLORIDE) KIT [IT3 MEDICAL LLC]	3	Legacy NDC, 1 package rows	20220302_5c32df04-cf50-45d5-9260-308ba585c407.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lidocaine Hydrochloride	LIDOCAINE HYDROCHLORIDE	Hospira, Inc.	3b2dd84e-cee8-4e58-d494-395a65a353a0	2026-01-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 088327 application number: ANDA088327
Lidocaine Hydrochloride	LIDOCAINE HYDROCHLORIDE	ProPharma Distribution	42d9e4cf-ca73-ec6d-e063-6394a90ae937	2025-12-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 088327 application number: ANDA088327
Lidocaine Hydrochloride	LIDOCAINE HYDROCHLORIDE ANHYDROUS	Henry Schein, Inc.	bb53bb10-bb36-4c9b-b632-71455615f9f3	2025-09-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 088327 application number: ANDA088327
1% LIDOCAINE HCI	1% LIDOCAINE HCI	HF Acquisition Co LLC, DBA HealthFirst	999b1c7b-3495-926a-e053-2a95a90ab206	2025-01-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 088327 application number: ANDA088327
2% LIDOCAINE HCI	2% LIDOCAINE HCI	HF Acquisition Co LLC, DBA HealthFirst	78d8fb0a-bfae-6599-e053-2991aa0a2e03	2024-01-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 088327 application number: ANDA088327
Lidocaine Hydrochloride	LIDOCAINE HYDROCHLORIDE	Medical Purchasing Solutions, LLC	8968c61e-2686-0fe6-e053-2a95a90a15fa	2023-05-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 088327 application number: ANDA088327
Lidocaine Hydrochloride	LIDOCAINE HYDROCHLORIDE	Medical Purchasing Solutions, LLC	858f3faa-e56e-51f9-e053-2a91aa0aa721	2023-05-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 088327 application number: ANDA088327

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1012404	BUPivacaine HCl 0.5 % Injectable Solution	PSN	5c32df04-cf50-45d5-9260-308ba585c407	3
797544	isopropyl alcohol 70 % Medicated Pad	PSN	5c32df04-cf50-45d5-9260-308ba585c407	3
1010671	lidocaine HCl 2 % Injectable Solution	PSN	5c32df04-cf50-45d5-9260-308ba585c407	3
1012406	Marcaine 0.5 % Injectable Solution	PSN	5c32df04-cf50-45d5-9260-308ba585c407	3
1012406	bupivacaine hydrochloride 5 MG/ML Injectable Solution [Marcaine]	SBD	5c32df04-cf50-45d5-9260-308ba585c407	3
1012404	bupivacaine hydrochloride 5 MG/ML Injectable Solution	SCD	5c32df04-cf50-45d5-9260-308ba585c407	3
797544	isopropyl alcohol 0.7 ML/ML Medicated Pad	SCD	5c32df04-cf50-45d5-9260-308ba585c407	3
1010671	lidocaine hydrochloride 20 MG/ML Injectable Solution	SCD	5c32df04-cf50-45d5-9260-308ba585c407	3
1012404	bupivacaine hydrochloride 0.5 % Injectable Solution	SY	5c32df04-cf50-45d5-9260-308ba585c407	3
797544	isopropyl alcohol 70 % Medicated Pad	SY	5c32df04-cf50-45d5-9260-308ba585c407	3
797544	isopropyl alcohol 70 % Topical Cloth	SY	5c32df04-cf50-45d5-9260-308ba585c407	3
797544	isopropyl alcohol 70 % Topical Swab	SY	5c32df04-cf50-45d5-9260-308ba585c407	3
1010671	lidocaine hydrochloride 2 % Injectable Solution	SY	5c32df04-cf50-45d5-9260-308ba585c407	3
1012406	Marcaine 0.5 % Injectable Solution	SY	5c32df04-cf50-45d5-9260-308ba585c407	3
1012406	Marcaine 5 MG/ML Injectable Solution	SY	5c32df04-cf50-45d5-9260-308ba585c407	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
70529-016-01	70529001601	1 KIT in 1 PACKAGE (70529-016-01) * 50 mL in 1 VIAL, MULTI-DOSE * 1 mL in 1 PACKET * 50 mL in 1 VIAL, MULTI-DOSE	1 kit	2017-03-01	0000-00-00	No	No	Current